SEC Form 4 · accession 0001209191-15-013862
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Curnutte
Officer — Executive Vice President
Period of report
Feb 13, 2015
Accepted (ET)
Feb 13, 2015 · 6:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2015 | M | 10,000 | $8.50 | A | 10,000 | D | |
| Common StockF2,F1 | Feb 13, 2015 | S | 10,000 | $32.50 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.50 | Feb 13, 2015 | M | 10,000 | D | Mar 23, 2011 | Mar 23, 2021 | Common Stock | 10,000 | 163,682 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2014.
- F2These shares were sold in a single transaction at a price of $32.50.